Related Experiment Video

Updated: Jun 15, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Thin blood and thinner margins in anticoagulation with left ventricular assist devices: Living on the Razor's Edge

Ameesh Isath1, Mandeep R Mehra1

  • 1Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|June 4, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K

Related Experiment Videos

Last Updated: Jun 15, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654

Articles linked to this work by shared authors, journal, and citation graph.

Frailty Patterns, Reversibility, and Outcomes With a Magnetically Levitated Left Ventricular Assist Device.

JACC. Heart failure·2026

10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients.

JACC. Heart failure·2026

Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial .

European heart journal·2026

Management of obesity in the contemporary LVAD era.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Digital Twins and Artificial Intelligence in Heart Failure: The Premise and the Promise.

Journal of cardiac failure·2026

Young adults in the cardiac intensive care unit: insights from the Critical Care Cardiology Trials Network registry.

European heart journal. Acute cardiovascular care·2025

"Interstitial lung disease with associated severe pulmonary hypertension is rarely idiopathic by clinical or pathologic measures".

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Ex vivo machine perfusion enables robust and widespread lipophilic-conjugated siRNA delivery to the porcine lung.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Association of donor single-cell cytokine secretion & circulating cytokine levels with the development & trajectory of severe primary graft dysfunction in lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

CLAD: translating basic science to clinical practice.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Bridging the Developmental Gap: Pediatric Considerations for the ISHLT Consensus Statement on Frailty in Lung Transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Letermovir for Primary Cytomegalovirus Prophylaxis in Pulmonary Fibrosis Lung.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us